Global Cold Sore Antiviral Drug Supply, Demand and Key Producers, 2023-2029
The global Cold Sore Antiviral Drug market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Cold Sore Antiviral Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cold Sore Antiviral Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cold Sore Antiviral Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cold Sore Antiviral Drug total market, 2018-2029, (USD Million)
Global Cold Sore Antiviral Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Cold Sore Antiviral Drug total market, key domestic companies and share, (USD Million)
Global Cold Sore Antiviral Drug revenue by player and market share 2018-2023, (USD Million)
Global Cold Sore Antiviral Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global Cold Sore Antiviral Drug total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Cold Sore Antiviral Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline, Ortho Dermatologics, Foundation Consumer Healthcare, Novartis, Teva Pharmaceuticals, Amneal Pharmaceuticals LLC, AiCuris, Apotex and Aurobindo Pharma USA, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cold Sore Antiviral Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Cold Sore Antiviral Drug Market, By Region:
1. How big is the global Cold Sore Antiviral Drug market?
2. What is the demand of the global Cold Sore Antiviral Drug market?
3. What is the year over year growth of the global Cold Sore Antiviral Drug market?
4. What is the total value of the global Cold Sore Antiviral Drug market?
5. Who are the major players in the global Cold Sore Antiviral Drug market?
6. What are the growth factors driving the market demand?
This report studies the global Cold Sore Antiviral Drug demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Cold Sore Antiviral Drug, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Cold Sore Antiviral Drug that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Cold Sore Antiviral Drug total market, 2018-2029, (USD Million)
Global Cold Sore Antiviral Drug total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Cold Sore Antiviral Drug total market, key domestic companies and share, (USD Million)
Global Cold Sore Antiviral Drug revenue by player and market share 2018-2023, (USD Million)
Global Cold Sore Antiviral Drug total market by Type, CAGR, 2018-2029, (USD Million)
Global Cold Sore Antiviral Drug total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Cold Sore Antiviral Drug market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include GlaxoSmithKline, Ortho Dermatologics, Foundation Consumer Healthcare, Novartis, Teva Pharmaceuticals, Amneal Pharmaceuticals LLC, AiCuris, Apotex and Aurobindo Pharma USA, Inc., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Cold Sore Antiviral Drug market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Cold Sore Antiviral Drug Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Smear
- Oral
- Others
- Child
- Aldult
- GlaxoSmithKline
- Ortho Dermatologics
- Foundation Consumer Healthcare
- Novartis
- Teva Pharmaceuticals
- Amneal Pharmaceuticals LLC
- AiCuris
- Apotex
- Aurobindo Pharma USA, Inc.
- Cipla
- Glenmark Pharmaceuticals, Inc.
- Hikma Pharmaceuticals
- HRA Pharma
- Hetero Healthcare Ltd
- Jubilant Cadista
- Merix Pharmaceutical Corp
- Sun Pharmaceutical Industries Ltd.
- Viatris
- Wockhardt
- Zydus Pharmaceuticals
1. How big is the global Cold Sore Antiviral Drug market?
2. What is the demand of the global Cold Sore Antiviral Drug market?
3. What is the year over year growth of the global Cold Sore Antiviral Drug market?
4. What is the total value of the global Cold Sore Antiviral Drug market?
5. Who are the major players in the global Cold Sore Antiviral Drug market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Cold Sore Antiviral Drug Introduction
1.2 World Cold Sore Antiviral Drug Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Cold Sore Antiviral Drug Total Market by Region (by Headquarter Location)
1.3.1 World Cold Sore Antiviral Drug Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Cold Sore Antiviral Drug Market Size (2018-2029)
1.3.3 China Cold Sore Antiviral Drug Market Size (2018-2029)
1.3.4 Europe Cold Sore Antiviral Drug Market Size (2018-2029)
1.3.5 Japan Cold Sore Antiviral Drug Market Size (2018-2029)
1.3.6 South Korea Cold Sore Antiviral Drug Market Size (2018-2029)
1.3.7 ASEAN Cold Sore Antiviral Drug Market Size (2018-2029)
1.3.8 India Cold Sore Antiviral Drug Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cold Sore Antiviral Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cold Sore Antiviral Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Cold Sore Antiviral Drug Consumption Value (2018-2029)
2.2 World Cold Sore Antiviral Drug Consumption Value by Region
2.2.1 World Cold Sore Antiviral Drug Consumption Value by Region (2018-2023)
2.2.2 World Cold Sore Antiviral Drug Consumption Value Forecast by Region (2024-2029)
2.3 United States Cold Sore Antiviral Drug Consumption Value (2018-2029)
2.4 China Cold Sore Antiviral Drug Consumption Value (2018-2029)
2.5 Europe Cold Sore Antiviral Drug Consumption Value (2018-2029)
2.6 Japan Cold Sore Antiviral Drug Consumption Value (2018-2029)
2.7 South Korea Cold Sore Antiviral Drug Consumption Value (2018-2029)
2.8 ASEAN Cold Sore Antiviral Drug Consumption Value (2018-2029)
2.9 India Cold Sore Antiviral Drug Consumption Value (2018-2029)
3 WORLD COLD SORE ANTIVIRAL DRUG COMPANIES COMPETITIVE ANALYSIS
3.1 World Cold Sore Antiviral Drug Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Cold Sore Antiviral Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Cold Sore Antiviral Drug in 2022
3.2.3 Global Concentration Ratios (CR8) for Cold Sore Antiviral Drug in 2022
3.3 Cold Sore Antiviral Drug Company Evaluation Quadrant
3.4 Cold Sore Antiviral Drug Market: Overall Company Footprint Analysis
3.4.1 Cold Sore Antiviral Drug Market: Region Footprint
3.4.2 Cold Sore Antiviral Drug Market: Company Product Type Footprint
3.4.3 Cold Sore Antiviral Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Cold Sore Antiviral Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Cold Sore Antiviral Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Cold Sore Antiviral Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Cold Sore Antiviral Drug Consumption Value Comparison
4.2.1 United States VS China: Cold Sore Antiviral Drug Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Cold Sore Antiviral Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Cold Sore Antiviral Drug Companies and Market Share, 2018-2023
4.3.1 United States Based Cold Sore Antiviral Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Cold Sore Antiviral Drug Revenue, (2018-2023)
4.4 China Based Companies Cold Sore Antiviral Drug Revenue and Market Share, 2018-2023
4.4.1 China Based Cold Sore Antiviral Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Cold Sore Antiviral Drug Revenue, (2018-2023)
4.5 Rest of World Based Cold Sore Antiviral Drug Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Cold Sore Antiviral Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Cold Sore Antiviral Drug Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Cold Sore Antiviral Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Smear
5.2.2 Oral
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Cold Sore Antiviral Drug Market Size by Type (2018-2023)
5.3.2 World Cold Sore Antiviral Drug Market Size by Type (2024-2029)
5.3.3 World Cold Sore Antiviral Drug Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Cold Sore Antiviral Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Child
6.2.2 Aldult
6.3 Market Segment by Application
6.3.1 World Cold Sore Antiviral Drug Market Size by Application (2018-2023)
6.3.2 World Cold Sore Antiviral Drug Market Size by Application (2024-2029)
6.3.3 World Cold Sore Antiviral Drug Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Details
7.1.2 GlaxoSmithKline Major Business
7.1.3 GlaxoSmithKline Cold Sore Antiviral Drug Product and Services
7.1.4 GlaxoSmithKline Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 GlaxoSmithKline Recent Developments/Updates
7.1.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.2 Ortho Dermatologics
7.2.1 Ortho Dermatologics Details
7.2.2 Ortho Dermatologics Major Business
7.2.3 Ortho Dermatologics Cold Sore Antiviral Drug Product and Services
7.2.4 Ortho Dermatologics Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Ortho Dermatologics Recent Developments/Updates
7.2.6 Ortho Dermatologics Competitive Strengths & Weaknesses
7.3 Foundation Consumer Healthcare
7.3.1 Foundation Consumer Healthcare Details
7.3.2 Foundation Consumer Healthcare Major Business
7.3.3 Foundation Consumer Healthcare Cold Sore Antiviral Drug Product and Services
7.3.4 Foundation Consumer Healthcare Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Foundation Consumer Healthcare Recent Developments/Updates
7.3.6 Foundation Consumer Healthcare Competitive Strengths & Weaknesses
7.4 Novartis
7.4.1 Novartis Details
7.4.2 Novartis Major Business
7.4.3 Novartis Cold Sore Antiviral Drug Product and Services
7.4.4 Novartis Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Novartis Recent Developments/Updates
7.4.6 Novartis Competitive Strengths & Weaknesses
7.5 Teva Pharmaceuticals
7.5.1 Teva Pharmaceuticals Details
7.5.2 Teva Pharmaceuticals Major Business
7.5.3 Teva Pharmaceuticals Cold Sore Antiviral Drug Product and Services
7.5.4 Teva Pharmaceuticals Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Teva Pharmaceuticals Recent Developments/Updates
7.5.6 Teva Pharmaceuticals Competitive Strengths & Weaknesses
7.6 Amneal Pharmaceuticals LLC
7.6.1 Amneal Pharmaceuticals LLC Details
7.6.2 Amneal Pharmaceuticals LLC Major Business
7.6.3 Amneal Pharmaceuticals LLC Cold Sore Antiviral Drug Product and Services
7.6.4 Amneal Pharmaceuticals LLC Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Amneal Pharmaceuticals LLC Recent Developments/Updates
7.6.6 Amneal Pharmaceuticals LLC Competitive Strengths & Weaknesses
7.7 AiCuris
7.7.1 AiCuris Details
7.7.2 AiCuris Major Business
7.7.3 AiCuris Cold Sore Antiviral Drug Product and Services
7.7.4 AiCuris Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 AiCuris Recent Developments/Updates
7.7.6 AiCuris Competitive Strengths & Weaknesses
7.8 Apotex
7.8.1 Apotex Details
7.8.2 Apotex Major Business
7.8.3 Apotex Cold Sore Antiviral Drug Product and Services
7.8.4 Apotex Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Apotex Recent Developments/Updates
7.8.6 Apotex Competitive Strengths & Weaknesses
7.9 Aurobindo Pharma USA, Inc.
7.9.1 Aurobindo Pharma USA, Inc. Details
7.9.2 Aurobindo Pharma USA, Inc. Major Business
7.9.3 Aurobindo Pharma USA, Inc. Cold Sore Antiviral Drug Product and Services
7.9.4 Aurobindo Pharma USA, Inc. Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Aurobindo Pharma USA, Inc. Recent Developments/Updates
7.9.6 Aurobindo Pharma USA, Inc. Competitive Strengths & Weaknesses
7.10 Cipla
7.10.1 Cipla Details
7.10.2 Cipla Major Business
7.10.3 Cipla Cold Sore Antiviral Drug Product and Services
7.10.4 Cipla Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Cipla Recent Developments/Updates
7.10.6 Cipla Competitive Strengths & Weaknesses
7.11 Glenmark Pharmaceuticals, Inc.
7.11.1 Glenmark Pharmaceuticals, Inc. Details
7.11.2 Glenmark Pharmaceuticals, Inc. Major Business
7.11.3 Glenmark Pharmaceuticals, Inc. Cold Sore Antiviral Drug Product and Services
7.11.4 Glenmark Pharmaceuticals, Inc. Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Glenmark Pharmaceuticals, Inc. Recent Developments/Updates
7.11.6 Glenmark Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
7.12 Hikma Pharmaceuticals
7.12.1 Hikma Pharmaceuticals Details
7.12.2 Hikma Pharmaceuticals Major Business
7.12.3 Hikma Pharmaceuticals Cold Sore Antiviral Drug Product and Services
7.12.4 Hikma Pharmaceuticals Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Hikma Pharmaceuticals Recent Developments/Updates
7.12.6 Hikma Pharmaceuticals Competitive Strengths & Weaknesses
7.13 HRA Pharma
7.13.1 HRA Pharma Details
7.13.2 HRA Pharma Major Business
7.13.3 HRA Pharma Cold Sore Antiviral Drug Product and Services
7.13.4 HRA Pharma Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 HRA Pharma Recent Developments/Updates
7.13.6 HRA Pharma Competitive Strengths & Weaknesses
7.14 Hetero Healthcare Ltd
7.14.1 Hetero Healthcare Ltd Details
7.14.2 Hetero Healthcare Ltd Major Business
7.14.3 Hetero Healthcare Ltd Cold Sore Antiviral Drug Product and Services
7.14.4 Hetero Healthcare Ltd Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Hetero Healthcare Ltd Recent Developments/Updates
7.14.6 Hetero Healthcare Ltd Competitive Strengths & Weaknesses
7.15 Jubilant Cadista
7.15.1 Jubilant Cadista Details
7.15.2 Jubilant Cadista Major Business
7.15.3 Jubilant Cadista Cold Sore Antiviral Drug Product and Services
7.15.4 Jubilant Cadista Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Jubilant Cadista Recent Developments/Updates
7.15.6 Jubilant Cadista Competitive Strengths & Weaknesses
7.16 Merix Pharmaceutical Corp
7.16.1 Merix Pharmaceutical Corp Details
7.16.2 Merix Pharmaceutical Corp Major Business
7.16.3 Merix Pharmaceutical Corp Cold Sore Antiviral Drug Product and Services
7.16.4 Merix Pharmaceutical Corp Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Merix Pharmaceutical Corp Recent Developments/Updates
7.16.6 Merix Pharmaceutical Corp Competitive Strengths & Weaknesses
7.17 Sun Pharmaceutical Industries Ltd.
7.17.1 Sun Pharmaceutical Industries Ltd. Details
7.17.2 Sun Pharmaceutical Industries Ltd. Major Business
7.17.3 Sun Pharmaceutical Industries Ltd. Cold Sore Antiviral Drug Product and Services
7.17.4 Sun Pharmaceutical Industries Ltd. Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
7.17.6 Sun Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
7.18 Viatris
7.18.1 Viatris Details
7.18.2 Viatris Major Business
7.18.3 Viatris Cold Sore Antiviral Drug Product and Services
7.18.4 Viatris Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Viatris Recent Developments/Updates
7.18.6 Viatris Competitive Strengths & Weaknesses
7.19 Wockhardt
7.19.1 Wockhardt Details
7.19.2 Wockhardt Major Business
7.19.3 Wockhardt Cold Sore Antiviral Drug Product and Services
7.19.4 Wockhardt Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Wockhardt Recent Developments/Updates
7.19.6 Wockhardt Competitive Strengths & Weaknesses
7.20 Zydus Pharmaceuticals
7.20.1 Zydus Pharmaceuticals Details
7.20.2 Zydus Pharmaceuticals Major Business
7.20.3 Zydus Pharmaceuticals Cold Sore Antiviral Drug Product and Services
7.20.4 Zydus Pharmaceuticals Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Zydus Pharmaceuticals Recent Developments/Updates
7.20.6 Zydus Pharmaceuticals Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Cold Sore Antiviral Drug Industry Chain
8.2 Cold Sore Antiviral Drug Upstream Analysis
8.3 Cold Sore Antiviral Drug Midstream Analysis
8.4 Cold Sore Antiviral Drug Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Cold Sore Antiviral Drug Introduction
1.2 World Cold Sore Antiviral Drug Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Cold Sore Antiviral Drug Total Market by Region (by Headquarter Location)
1.3.1 World Cold Sore Antiviral Drug Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Cold Sore Antiviral Drug Market Size (2018-2029)
1.3.3 China Cold Sore Antiviral Drug Market Size (2018-2029)
1.3.4 Europe Cold Sore Antiviral Drug Market Size (2018-2029)
1.3.5 Japan Cold Sore Antiviral Drug Market Size (2018-2029)
1.3.6 South Korea Cold Sore Antiviral Drug Market Size (2018-2029)
1.3.7 ASEAN Cold Sore Antiviral Drug Market Size (2018-2029)
1.3.8 India Cold Sore Antiviral Drug Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Cold Sore Antiviral Drug Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Cold Sore Antiviral Drug Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Cold Sore Antiviral Drug Consumption Value (2018-2029)
2.2 World Cold Sore Antiviral Drug Consumption Value by Region
2.2.1 World Cold Sore Antiviral Drug Consumption Value by Region (2018-2023)
2.2.2 World Cold Sore Antiviral Drug Consumption Value Forecast by Region (2024-2029)
2.3 United States Cold Sore Antiviral Drug Consumption Value (2018-2029)
2.4 China Cold Sore Antiviral Drug Consumption Value (2018-2029)
2.5 Europe Cold Sore Antiviral Drug Consumption Value (2018-2029)
2.6 Japan Cold Sore Antiviral Drug Consumption Value (2018-2029)
2.7 South Korea Cold Sore Antiviral Drug Consumption Value (2018-2029)
2.8 ASEAN Cold Sore Antiviral Drug Consumption Value (2018-2029)
2.9 India Cold Sore Antiviral Drug Consumption Value (2018-2029)
3 WORLD COLD SORE ANTIVIRAL DRUG COMPANIES COMPETITIVE ANALYSIS
3.1 World Cold Sore Antiviral Drug Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Cold Sore Antiviral Drug Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Cold Sore Antiviral Drug in 2022
3.2.3 Global Concentration Ratios (CR8) for Cold Sore Antiviral Drug in 2022
3.3 Cold Sore Antiviral Drug Company Evaluation Quadrant
3.4 Cold Sore Antiviral Drug Market: Overall Company Footprint Analysis
3.4.1 Cold Sore Antiviral Drug Market: Region Footprint
3.4.2 Cold Sore Antiviral Drug Market: Company Product Type Footprint
3.4.3 Cold Sore Antiviral Drug Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Cold Sore Antiviral Drug Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Cold Sore Antiviral Drug Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Cold Sore Antiviral Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Cold Sore Antiviral Drug Consumption Value Comparison
4.2.1 United States VS China: Cold Sore Antiviral Drug Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Cold Sore Antiviral Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Cold Sore Antiviral Drug Companies and Market Share, 2018-2023
4.3.1 United States Based Cold Sore Antiviral Drug Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Cold Sore Antiviral Drug Revenue, (2018-2023)
4.4 China Based Companies Cold Sore Antiviral Drug Revenue and Market Share, 2018-2023
4.4.1 China Based Cold Sore Antiviral Drug Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Cold Sore Antiviral Drug Revenue, (2018-2023)
4.5 Rest of World Based Cold Sore Antiviral Drug Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Cold Sore Antiviral Drug Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Cold Sore Antiviral Drug Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Cold Sore Antiviral Drug Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Smear
5.2.2 Oral
5.2.3 Others
5.3 Market Segment by Type
5.3.1 World Cold Sore Antiviral Drug Market Size by Type (2018-2023)
5.3.2 World Cold Sore Antiviral Drug Market Size by Type (2024-2029)
5.3.3 World Cold Sore Antiviral Drug Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Cold Sore Antiviral Drug Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Child
6.2.2 Aldult
6.3 Market Segment by Application
6.3.1 World Cold Sore Antiviral Drug Market Size by Application (2018-2023)
6.3.2 World Cold Sore Antiviral Drug Market Size by Application (2024-2029)
6.3.3 World Cold Sore Antiviral Drug Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 GlaxoSmithKline
7.1.1 GlaxoSmithKline Details
7.1.2 GlaxoSmithKline Major Business
7.1.3 GlaxoSmithKline Cold Sore Antiviral Drug Product and Services
7.1.4 GlaxoSmithKline Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 GlaxoSmithKline Recent Developments/Updates
7.1.6 GlaxoSmithKline Competitive Strengths & Weaknesses
7.2 Ortho Dermatologics
7.2.1 Ortho Dermatologics Details
7.2.2 Ortho Dermatologics Major Business
7.2.3 Ortho Dermatologics Cold Sore Antiviral Drug Product and Services
7.2.4 Ortho Dermatologics Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Ortho Dermatologics Recent Developments/Updates
7.2.6 Ortho Dermatologics Competitive Strengths & Weaknesses
7.3 Foundation Consumer Healthcare
7.3.1 Foundation Consumer Healthcare Details
7.3.2 Foundation Consumer Healthcare Major Business
7.3.3 Foundation Consumer Healthcare Cold Sore Antiviral Drug Product and Services
7.3.4 Foundation Consumer Healthcare Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Foundation Consumer Healthcare Recent Developments/Updates
7.3.6 Foundation Consumer Healthcare Competitive Strengths & Weaknesses
7.4 Novartis
7.4.1 Novartis Details
7.4.2 Novartis Major Business
7.4.3 Novartis Cold Sore Antiviral Drug Product and Services
7.4.4 Novartis Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Novartis Recent Developments/Updates
7.4.6 Novartis Competitive Strengths & Weaknesses
7.5 Teva Pharmaceuticals
7.5.1 Teva Pharmaceuticals Details
7.5.2 Teva Pharmaceuticals Major Business
7.5.3 Teva Pharmaceuticals Cold Sore Antiviral Drug Product and Services
7.5.4 Teva Pharmaceuticals Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 Teva Pharmaceuticals Recent Developments/Updates
7.5.6 Teva Pharmaceuticals Competitive Strengths & Weaknesses
7.6 Amneal Pharmaceuticals LLC
7.6.1 Amneal Pharmaceuticals LLC Details
7.6.2 Amneal Pharmaceuticals LLC Major Business
7.6.3 Amneal Pharmaceuticals LLC Cold Sore Antiviral Drug Product and Services
7.6.4 Amneal Pharmaceuticals LLC Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Amneal Pharmaceuticals LLC Recent Developments/Updates
7.6.6 Amneal Pharmaceuticals LLC Competitive Strengths & Weaknesses
7.7 AiCuris
7.7.1 AiCuris Details
7.7.2 AiCuris Major Business
7.7.3 AiCuris Cold Sore Antiviral Drug Product and Services
7.7.4 AiCuris Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 AiCuris Recent Developments/Updates
7.7.6 AiCuris Competitive Strengths & Weaknesses
7.8 Apotex
7.8.1 Apotex Details
7.8.2 Apotex Major Business
7.8.3 Apotex Cold Sore Antiviral Drug Product and Services
7.8.4 Apotex Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Apotex Recent Developments/Updates
7.8.6 Apotex Competitive Strengths & Weaknesses
7.9 Aurobindo Pharma USA, Inc.
7.9.1 Aurobindo Pharma USA, Inc. Details
7.9.2 Aurobindo Pharma USA, Inc. Major Business
7.9.3 Aurobindo Pharma USA, Inc. Cold Sore Antiviral Drug Product and Services
7.9.4 Aurobindo Pharma USA, Inc. Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Aurobindo Pharma USA, Inc. Recent Developments/Updates
7.9.6 Aurobindo Pharma USA, Inc. Competitive Strengths & Weaknesses
7.10 Cipla
7.10.1 Cipla Details
7.10.2 Cipla Major Business
7.10.3 Cipla Cold Sore Antiviral Drug Product and Services
7.10.4 Cipla Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Cipla Recent Developments/Updates
7.10.6 Cipla Competitive Strengths & Weaknesses
7.11 Glenmark Pharmaceuticals, Inc.
7.11.1 Glenmark Pharmaceuticals, Inc. Details
7.11.2 Glenmark Pharmaceuticals, Inc. Major Business
7.11.3 Glenmark Pharmaceuticals, Inc. Cold Sore Antiviral Drug Product and Services
7.11.4 Glenmark Pharmaceuticals, Inc. Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 Glenmark Pharmaceuticals, Inc. Recent Developments/Updates
7.11.6 Glenmark Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
7.12 Hikma Pharmaceuticals
7.12.1 Hikma Pharmaceuticals Details
7.12.2 Hikma Pharmaceuticals Major Business
7.12.3 Hikma Pharmaceuticals Cold Sore Antiviral Drug Product and Services
7.12.4 Hikma Pharmaceuticals Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.12.5 Hikma Pharmaceuticals Recent Developments/Updates
7.12.6 Hikma Pharmaceuticals Competitive Strengths & Weaknesses
7.13 HRA Pharma
7.13.1 HRA Pharma Details
7.13.2 HRA Pharma Major Business
7.13.3 HRA Pharma Cold Sore Antiviral Drug Product and Services
7.13.4 HRA Pharma Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.13.5 HRA Pharma Recent Developments/Updates
7.13.6 HRA Pharma Competitive Strengths & Weaknesses
7.14 Hetero Healthcare Ltd
7.14.1 Hetero Healthcare Ltd Details
7.14.2 Hetero Healthcare Ltd Major Business
7.14.3 Hetero Healthcare Ltd Cold Sore Antiviral Drug Product and Services
7.14.4 Hetero Healthcare Ltd Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.14.5 Hetero Healthcare Ltd Recent Developments/Updates
7.14.6 Hetero Healthcare Ltd Competitive Strengths & Weaknesses
7.15 Jubilant Cadista
7.15.1 Jubilant Cadista Details
7.15.2 Jubilant Cadista Major Business
7.15.3 Jubilant Cadista Cold Sore Antiviral Drug Product and Services
7.15.4 Jubilant Cadista Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.15.5 Jubilant Cadista Recent Developments/Updates
7.15.6 Jubilant Cadista Competitive Strengths & Weaknesses
7.16 Merix Pharmaceutical Corp
7.16.1 Merix Pharmaceutical Corp Details
7.16.2 Merix Pharmaceutical Corp Major Business
7.16.3 Merix Pharmaceutical Corp Cold Sore Antiviral Drug Product and Services
7.16.4 Merix Pharmaceutical Corp Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.16.5 Merix Pharmaceutical Corp Recent Developments/Updates
7.16.6 Merix Pharmaceutical Corp Competitive Strengths & Weaknesses
7.17 Sun Pharmaceutical Industries Ltd.
7.17.1 Sun Pharmaceutical Industries Ltd. Details
7.17.2 Sun Pharmaceutical Industries Ltd. Major Business
7.17.3 Sun Pharmaceutical Industries Ltd. Cold Sore Antiviral Drug Product and Services
7.17.4 Sun Pharmaceutical Industries Ltd. Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.17.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
7.17.6 Sun Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
7.18 Viatris
7.18.1 Viatris Details
7.18.2 Viatris Major Business
7.18.3 Viatris Cold Sore Antiviral Drug Product and Services
7.18.4 Viatris Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.18.5 Viatris Recent Developments/Updates
7.18.6 Viatris Competitive Strengths & Weaknesses
7.19 Wockhardt
7.19.1 Wockhardt Details
7.19.2 Wockhardt Major Business
7.19.3 Wockhardt Cold Sore Antiviral Drug Product and Services
7.19.4 Wockhardt Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.19.5 Wockhardt Recent Developments/Updates
7.19.6 Wockhardt Competitive Strengths & Weaknesses
7.20 Zydus Pharmaceuticals
7.20.1 Zydus Pharmaceuticals Details
7.20.2 Zydus Pharmaceuticals Major Business
7.20.3 Zydus Pharmaceuticals Cold Sore Antiviral Drug Product and Services
7.20.4 Zydus Pharmaceuticals Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023)
7.20.5 Zydus Pharmaceuticals Recent Developments/Updates
7.20.6 Zydus Pharmaceuticals Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Cold Sore Antiviral Drug Industry Chain
8.2 Cold Sore Antiviral Drug Upstream Analysis
8.3 Cold Sore Antiviral Drug Midstream Analysis
8.4 Cold Sore Antiviral Drug Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Cold Sore Antiviral Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Cold Sore Antiviral Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Cold Sore Antiviral Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Cold Sore Antiviral Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Cold Sore Antiviral Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cold Sore Antiviral Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Cold Sore Antiviral Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Cold Sore Antiviral Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Cold Sore Antiviral Drug Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Cold Sore Antiviral Drug Players in 2022
Table 12. World Cold Sore Antiviral Drug Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Cold Sore Antiviral Drug Company Evaluation Quadrant
Table 14. Head Office of Key Cold Sore Antiviral Drug Player
Table 15. Cold Sore Antiviral Drug Market: Company Product Type Footprint
Table 16. Cold Sore Antiviral Drug Market: Company Product Application Footprint
Table 17. Cold Sore Antiviral Drug Mergers & Acquisitions Activity
Table 18. United States VS China Cold Sore Antiviral Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Cold Sore Antiviral Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Cold Sore Antiviral Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cold Sore Antiviral Drug Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Cold Sore Antiviral Drug Revenue Market Share (2018-2023)
Table 23. China Based Cold Sore Antiviral Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cold Sore Antiviral Drug Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Cold Sore Antiviral Drug Revenue Market Share (2018-2023)
Table 26. Rest of World Based Cold Sore Antiviral Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Cold Sore Antiviral Drug Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Cold Sore Antiviral Drug Revenue Market Share (2018-2023)
Table 29. World Cold Sore Antiviral Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Cold Sore Antiviral Drug Market Size by Type (2018-2023) & (USD Million)
Table 31. World Cold Sore Antiviral Drug Market Size by Type (2024-2029) & (USD Million)
Table 32. World Cold Sore Antiviral Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Cold Sore Antiviral Drug Market Size by Application (2018-2023) & (USD Million)
Table 34. World Cold Sore Antiviral Drug Market Size by Application (2024-2029) & (USD Million)
Table 35. GlaxoSmithKline Basic Information, Area Served and Competitors
Table 36. GlaxoSmithKline Major Business
Table 37. GlaxoSmithKline Cold Sore Antiviral Drug Product and Services
Table 38. GlaxoSmithKline Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. GlaxoSmithKline Recent Developments/Updates
Table 40. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 41. Ortho Dermatologics Basic Information, Area Served and Competitors
Table 42. Ortho Dermatologics Major Business
Table 43. Ortho Dermatologics Cold Sore Antiviral Drug Product and Services
Table 44. Ortho Dermatologics Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Ortho Dermatologics Recent Developments/Updates
Table 46. Ortho Dermatologics Competitive Strengths & Weaknesses
Table 47. Foundation Consumer Healthcare Basic Information, Area Served and Competitors
Table 48. Foundation Consumer Healthcare Major Business
Table 49. Foundation Consumer Healthcare Cold Sore Antiviral Drug Product and Services
Table 50. Foundation Consumer Healthcare Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Foundation Consumer Healthcare Recent Developments/Updates
Table 52. Foundation Consumer Healthcare Competitive Strengths & Weaknesses
Table 53. Novartis Basic Information, Area Served and Competitors
Table 54. Novartis Major Business
Table 55. Novartis Cold Sore Antiviral Drug Product and Services
Table 56. Novartis Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Novartis Recent Developments/Updates
Table 58. Novartis Competitive Strengths & Weaknesses
Table 59. Teva Pharmaceuticals Basic Information, Area Served and Competitors
Table 60. Teva Pharmaceuticals Major Business
Table 61. Teva Pharmaceuticals Cold Sore Antiviral Drug Product and Services
Table 62. Teva Pharmaceuticals Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Teva Pharmaceuticals Recent Developments/Updates
Table 64. Teva Pharmaceuticals Competitive Strengths & Weaknesses
Table 65. Amneal Pharmaceuticals LLC Basic Information, Area Served and Competitors
Table 66. Amneal Pharmaceuticals LLC Major Business
Table 67. Amneal Pharmaceuticals LLC Cold Sore Antiviral Drug Product and Services
Table 68. Amneal Pharmaceuticals LLC Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Amneal Pharmaceuticals LLC Recent Developments/Updates
Table 70. Amneal Pharmaceuticals LLC Competitive Strengths & Weaknesses
Table 71. AiCuris Basic Information, Area Served and Competitors
Table 72. AiCuris Major Business
Table 73. AiCuris Cold Sore Antiviral Drug Product and Services
Table 74. AiCuris Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. AiCuris Recent Developments/Updates
Table 76. AiCuris Competitive Strengths & Weaknesses
Table 77. Apotex Basic Information, Area Served and Competitors
Table 78. Apotex Major Business
Table 79. Apotex Cold Sore Antiviral Drug Product and Services
Table 80. Apotex Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Apotex Recent Developments/Updates
Table 82. Apotex Competitive Strengths & Weaknesses
Table 83. Aurobindo Pharma USA, Inc. Basic Information, Area Served and Competitors
Table 84. Aurobindo Pharma USA, Inc. Major Business
Table 85. Aurobindo Pharma USA, Inc. Cold Sore Antiviral Drug Product and Services
Table 86. Aurobindo Pharma USA, Inc. Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Aurobindo Pharma USA, Inc. Recent Developments/Updates
Table 88. Aurobindo Pharma USA, Inc. Competitive Strengths & Weaknesses
Table 89. Cipla Basic Information, Area Served and Competitors
Table 90. Cipla Major Business
Table 91. Cipla Cold Sore Antiviral Drug Product and Services
Table 92. Cipla Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Cipla Recent Developments/Updates
Table 94. Cipla Competitive Strengths & Weaknesses
Table 95. Glenmark Pharmaceuticals, Inc. Basic Information, Area Served and Competitors
Table 96. Glenmark Pharmaceuticals, Inc. Major Business
Table 97. Glenmark Pharmaceuticals, Inc. Cold Sore Antiviral Drug Product and Services
Table 98. Glenmark Pharmaceuticals, Inc. Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Glenmark Pharmaceuticals, Inc. Recent Developments/Updates
Table 100. Glenmark Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
Table 101. Hikma Pharmaceuticals Basic Information, Area Served and Competitors
Table 102. Hikma Pharmaceuticals Major Business
Table 103. Hikma Pharmaceuticals Cold Sore Antiviral Drug Product and Services
Table 104. Hikma Pharmaceuticals Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Hikma Pharmaceuticals Recent Developments/Updates
Table 106. Hikma Pharmaceuticals Competitive Strengths & Weaknesses
Table 107. HRA Pharma Basic Information, Area Served and Competitors
Table 108. HRA Pharma Major Business
Table 109. HRA Pharma Cold Sore Antiviral Drug Product and Services
Table 110. HRA Pharma Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. HRA Pharma Recent Developments/Updates
Table 112. HRA Pharma Competitive Strengths & Weaknesses
Table 113. Hetero Healthcare Ltd Basic Information, Area Served and Competitors
Table 114. Hetero Healthcare Ltd Major Business
Table 115. Hetero Healthcare Ltd Cold Sore Antiviral Drug Product and Services
Table 116. Hetero Healthcare Ltd Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Hetero Healthcare Ltd Recent Developments/Updates
Table 118. Hetero Healthcare Ltd Competitive Strengths & Weaknesses
Table 119. Jubilant Cadista Basic Information, Area Served and Competitors
Table 120. Jubilant Cadista Major Business
Table 121. Jubilant Cadista Cold Sore Antiviral Drug Product and Services
Table 122. Jubilant Cadista Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Jubilant Cadista Recent Developments/Updates
Table 124. Jubilant Cadista Competitive Strengths & Weaknesses
Table 125. Merix Pharmaceutical Corp Basic Information, Area Served and Competitors
Table 126. Merix Pharmaceutical Corp Major Business
Table 127. Merix Pharmaceutical Corp Cold Sore Antiviral Drug Product and Services
Table 128. Merix Pharmaceutical Corp Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Merix Pharmaceutical Corp Recent Developments/Updates
Table 130. Merix Pharmaceutical Corp Competitive Strengths & Weaknesses
Table 131. Sun Pharmaceutical Industries Ltd. Basic Information, Area Served and Competitors
Table 132. Sun Pharmaceutical Industries Ltd. Major Business
Table 133. Sun Pharmaceutical Industries Ltd. Cold Sore Antiviral Drug Product and Services
Table 134. Sun Pharmaceutical Industries Ltd. Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 136. Sun Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
Table 137. Viatris Basic Information, Area Served and Competitors
Table 138. Viatris Major Business
Table 139. Viatris Cold Sore Antiviral Drug Product and Services
Table 140. Viatris Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Viatris Recent Developments/Updates
Table 142. Viatris Competitive Strengths & Weaknesses
Table 143. Wockhardt Basic Information, Area Served and Competitors
Table 144. Wockhardt Major Business
Table 145. Wockhardt Cold Sore Antiviral Drug Product and Services
Table 146. Wockhardt Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Wockhardt Recent Developments/Updates
Table 148. Zydus Pharmaceuticals Basic Information, Area Served and Competitors
Table 149. Zydus Pharmaceuticals Major Business
Table 150. Zydus Pharmaceuticals Cold Sore Antiviral Drug Product and Services
Table 151. Zydus Pharmaceuticals Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 152. Global Key Players of Cold Sore Antiviral Drug Upstream (Raw Materials)
Table 153. Cold Sore Antiviral Drug Typical Customers
Table 1. World Cold Sore Antiviral Drug Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Cold Sore Antiviral Drug Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Cold Sore Antiviral Drug Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Cold Sore Antiviral Drug Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Cold Sore Antiviral Drug Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Cold Sore Antiviral Drug Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Cold Sore Antiviral Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Cold Sore Antiviral Drug Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Cold Sore Antiviral Drug Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Cold Sore Antiviral Drug Players in 2022
Table 12. World Cold Sore Antiviral Drug Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Cold Sore Antiviral Drug Company Evaluation Quadrant
Table 14. Head Office of Key Cold Sore Antiviral Drug Player
Table 15. Cold Sore Antiviral Drug Market: Company Product Type Footprint
Table 16. Cold Sore Antiviral Drug Market: Company Product Application Footprint
Table 17. Cold Sore Antiviral Drug Mergers & Acquisitions Activity
Table 18. United States VS China Cold Sore Antiviral Drug Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Cold Sore Antiviral Drug Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Cold Sore Antiviral Drug Companies, Headquarters (States, Country)
Table 21. United States Based Companies Cold Sore Antiviral Drug Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Cold Sore Antiviral Drug Revenue Market Share (2018-2023)
Table 23. China Based Cold Sore Antiviral Drug Companies, Headquarters (Province, Country)
Table 24. China Based Companies Cold Sore Antiviral Drug Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Cold Sore Antiviral Drug Revenue Market Share (2018-2023)
Table 26. Rest of World Based Cold Sore Antiviral Drug Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Cold Sore Antiviral Drug Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Cold Sore Antiviral Drug Revenue Market Share (2018-2023)
Table 29. World Cold Sore Antiviral Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Cold Sore Antiviral Drug Market Size by Type (2018-2023) & (USD Million)
Table 31. World Cold Sore Antiviral Drug Market Size by Type (2024-2029) & (USD Million)
Table 32. World Cold Sore Antiviral Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Cold Sore Antiviral Drug Market Size by Application (2018-2023) & (USD Million)
Table 34. World Cold Sore Antiviral Drug Market Size by Application (2024-2029) & (USD Million)
Table 35. GlaxoSmithKline Basic Information, Area Served and Competitors
Table 36. GlaxoSmithKline Major Business
Table 37. GlaxoSmithKline Cold Sore Antiviral Drug Product and Services
Table 38. GlaxoSmithKline Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. GlaxoSmithKline Recent Developments/Updates
Table 40. GlaxoSmithKline Competitive Strengths & Weaknesses
Table 41. Ortho Dermatologics Basic Information, Area Served and Competitors
Table 42. Ortho Dermatologics Major Business
Table 43. Ortho Dermatologics Cold Sore Antiviral Drug Product and Services
Table 44. Ortho Dermatologics Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Ortho Dermatologics Recent Developments/Updates
Table 46. Ortho Dermatologics Competitive Strengths & Weaknesses
Table 47. Foundation Consumer Healthcare Basic Information, Area Served and Competitors
Table 48. Foundation Consumer Healthcare Major Business
Table 49. Foundation Consumer Healthcare Cold Sore Antiviral Drug Product and Services
Table 50. Foundation Consumer Healthcare Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Foundation Consumer Healthcare Recent Developments/Updates
Table 52. Foundation Consumer Healthcare Competitive Strengths & Weaknesses
Table 53. Novartis Basic Information, Area Served and Competitors
Table 54. Novartis Major Business
Table 55. Novartis Cold Sore Antiviral Drug Product and Services
Table 56. Novartis Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Novartis Recent Developments/Updates
Table 58. Novartis Competitive Strengths & Weaknesses
Table 59. Teva Pharmaceuticals Basic Information, Area Served and Competitors
Table 60. Teva Pharmaceuticals Major Business
Table 61. Teva Pharmaceuticals Cold Sore Antiviral Drug Product and Services
Table 62. Teva Pharmaceuticals Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Teva Pharmaceuticals Recent Developments/Updates
Table 64. Teva Pharmaceuticals Competitive Strengths & Weaknesses
Table 65. Amneal Pharmaceuticals LLC Basic Information, Area Served and Competitors
Table 66. Amneal Pharmaceuticals LLC Major Business
Table 67. Amneal Pharmaceuticals LLC Cold Sore Antiviral Drug Product and Services
Table 68. Amneal Pharmaceuticals LLC Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Amneal Pharmaceuticals LLC Recent Developments/Updates
Table 70. Amneal Pharmaceuticals LLC Competitive Strengths & Weaknesses
Table 71. AiCuris Basic Information, Area Served and Competitors
Table 72. AiCuris Major Business
Table 73. AiCuris Cold Sore Antiviral Drug Product and Services
Table 74. AiCuris Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. AiCuris Recent Developments/Updates
Table 76. AiCuris Competitive Strengths & Weaknesses
Table 77. Apotex Basic Information, Area Served and Competitors
Table 78. Apotex Major Business
Table 79. Apotex Cold Sore Antiviral Drug Product and Services
Table 80. Apotex Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Apotex Recent Developments/Updates
Table 82. Apotex Competitive Strengths & Weaknesses
Table 83. Aurobindo Pharma USA, Inc. Basic Information, Area Served and Competitors
Table 84. Aurobindo Pharma USA, Inc. Major Business
Table 85. Aurobindo Pharma USA, Inc. Cold Sore Antiviral Drug Product and Services
Table 86. Aurobindo Pharma USA, Inc. Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Aurobindo Pharma USA, Inc. Recent Developments/Updates
Table 88. Aurobindo Pharma USA, Inc. Competitive Strengths & Weaknesses
Table 89. Cipla Basic Information, Area Served and Competitors
Table 90. Cipla Major Business
Table 91. Cipla Cold Sore Antiviral Drug Product and Services
Table 92. Cipla Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Cipla Recent Developments/Updates
Table 94. Cipla Competitive Strengths & Weaknesses
Table 95. Glenmark Pharmaceuticals, Inc. Basic Information, Area Served and Competitors
Table 96. Glenmark Pharmaceuticals, Inc. Major Business
Table 97. Glenmark Pharmaceuticals, Inc. Cold Sore Antiviral Drug Product and Services
Table 98. Glenmark Pharmaceuticals, Inc. Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Glenmark Pharmaceuticals, Inc. Recent Developments/Updates
Table 100. Glenmark Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
Table 101. Hikma Pharmaceuticals Basic Information, Area Served and Competitors
Table 102. Hikma Pharmaceuticals Major Business
Table 103. Hikma Pharmaceuticals Cold Sore Antiviral Drug Product and Services
Table 104. Hikma Pharmaceuticals Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. Hikma Pharmaceuticals Recent Developments/Updates
Table 106. Hikma Pharmaceuticals Competitive Strengths & Weaknesses
Table 107. HRA Pharma Basic Information, Area Served and Competitors
Table 108. HRA Pharma Major Business
Table 109. HRA Pharma Cold Sore Antiviral Drug Product and Services
Table 110. HRA Pharma Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. HRA Pharma Recent Developments/Updates
Table 112. HRA Pharma Competitive Strengths & Weaknesses
Table 113. Hetero Healthcare Ltd Basic Information, Area Served and Competitors
Table 114. Hetero Healthcare Ltd Major Business
Table 115. Hetero Healthcare Ltd Cold Sore Antiviral Drug Product and Services
Table 116. Hetero Healthcare Ltd Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Hetero Healthcare Ltd Recent Developments/Updates
Table 118. Hetero Healthcare Ltd Competitive Strengths & Weaknesses
Table 119. Jubilant Cadista Basic Information, Area Served and Competitors
Table 120. Jubilant Cadista Major Business
Table 121. Jubilant Cadista Cold Sore Antiviral Drug Product and Services
Table 122. Jubilant Cadista Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Jubilant Cadista Recent Developments/Updates
Table 124. Jubilant Cadista Competitive Strengths & Weaknesses
Table 125. Merix Pharmaceutical Corp Basic Information, Area Served and Competitors
Table 126. Merix Pharmaceutical Corp Major Business
Table 127. Merix Pharmaceutical Corp Cold Sore Antiviral Drug Product and Services
Table 128. Merix Pharmaceutical Corp Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Merix Pharmaceutical Corp Recent Developments/Updates
Table 130. Merix Pharmaceutical Corp Competitive Strengths & Weaknesses
Table 131. Sun Pharmaceutical Industries Ltd. Basic Information, Area Served and Competitors
Table 132. Sun Pharmaceutical Industries Ltd. Major Business
Table 133. Sun Pharmaceutical Industries Ltd. Cold Sore Antiviral Drug Product and Services
Table 134. Sun Pharmaceutical Industries Ltd. Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 136. Sun Pharmaceutical Industries Ltd. Competitive Strengths & Weaknesses
Table 137. Viatris Basic Information, Area Served and Competitors
Table 138. Viatris Major Business
Table 139. Viatris Cold Sore Antiviral Drug Product and Services
Table 140. Viatris Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 141. Viatris Recent Developments/Updates
Table 142. Viatris Competitive Strengths & Weaknesses
Table 143. Wockhardt Basic Information, Area Served and Competitors
Table 144. Wockhardt Major Business
Table 145. Wockhardt Cold Sore Antiviral Drug Product and Services
Table 146. Wockhardt Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 147. Wockhardt Recent Developments/Updates
Table 148. Zydus Pharmaceuticals Basic Information, Area Served and Competitors
Table 149. Zydus Pharmaceuticals Major Business
Table 150. Zydus Pharmaceuticals Cold Sore Antiviral Drug Product and Services
Table 151. Zydus Pharmaceuticals Cold Sore Antiviral Drug Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 152. Global Key Players of Cold Sore Antiviral Drug Upstream (Raw Materials)
Table 153. Cold Sore Antiviral Drug Typical Customers
LIST OF FIGURES
Figure 1. Cold Sore Antiviral Drug Picture
Figure 2. World Cold Sore Antiviral Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Cold Sore Antiviral Drug Total Market Size (2018-2029) & (USD Million)
Figure 4. World Cold Sore Antiviral Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Cold Sore Antiviral Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Cold Sore Antiviral Drug Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Cold Sore Antiviral Drug Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Cold Sore Antiviral Drug Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Cold Sore Antiviral Drug Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Cold Sore Antiviral Drug Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Cold Sore Antiviral Drug Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Cold Sore Antiviral Drug Revenue (2018-2029) & (USD Million)
Figure 13. Cold Sore Antiviral Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cold Sore Antiviral Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. World Cold Sore Antiviral Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Cold Sore Antiviral Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. China Cold Sore Antiviral Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Cold Sore Antiviral Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Cold Sore Antiviral Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Cold Sore Antiviral Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Cold Sore Antiviral Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. India Cold Sore Antiviral Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Cold Sore Antiviral Drug by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cold Sore Antiviral Drug Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cold Sore Antiviral Drug Markets in 2022
Figure 27. United States VS China: Cold Sore Antiviral Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Cold Sore Antiviral Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Cold Sore Antiviral Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Cold Sore Antiviral Drug Market Size Market Share by Type in 2022
Figure 31. Smear
Figure 32. Oral
Figure 33. Others
Figure 34. World Cold Sore Antiviral Drug Market Size Market Share by Type (2018-2029)
Figure 35. World Cold Sore Antiviral Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Cold Sore Antiviral Drug Market Size Market Share by Application in 2022
Figure 37. Child
Figure 38. Aldult
Figure 39. Cold Sore Antiviral Drug Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
Figure 1. Cold Sore Antiviral Drug Picture
Figure 2. World Cold Sore Antiviral Drug Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Cold Sore Antiviral Drug Total Market Size (2018-2029) & (USD Million)
Figure 4. World Cold Sore Antiviral Drug Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Cold Sore Antiviral Drug Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Cold Sore Antiviral Drug Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Cold Sore Antiviral Drug Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Cold Sore Antiviral Drug Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Cold Sore Antiviral Drug Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Cold Sore Antiviral Drug Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Cold Sore Antiviral Drug Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Cold Sore Antiviral Drug Revenue (2018-2029) & (USD Million)
Figure 13. Cold Sore Antiviral Drug Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Cold Sore Antiviral Drug Consumption Value (2018-2029) & (USD Million)
Figure 16. World Cold Sore Antiviral Drug Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Cold Sore Antiviral Drug Consumption Value (2018-2029) & (USD Million)
Figure 18. China Cold Sore Antiviral Drug Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Cold Sore Antiviral Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Cold Sore Antiviral Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Cold Sore Antiviral Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Cold Sore Antiviral Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. India Cold Sore Antiviral Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Cold Sore Antiviral Drug by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Cold Sore Antiviral Drug Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Cold Sore Antiviral Drug Markets in 2022
Figure 27. United States VS China: Cold Sore Antiviral Drug Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Cold Sore Antiviral Drug Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Cold Sore Antiviral Drug Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Cold Sore Antiviral Drug Market Size Market Share by Type in 2022
Figure 31. Smear
Figure 32. Oral
Figure 33. Others
Figure 34. World Cold Sore Antiviral Drug Market Size Market Share by Type (2018-2029)
Figure 35. World Cold Sore Antiviral Drug Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 36. World Cold Sore Antiviral Drug Market Size Market Share by Application in 2022
Figure 37. Child
Figure 38. Aldult
Figure 39. Cold Sore Antiviral Drug Industrial Chain
Figure 40. Methodology
Figure 41. Research Process and Data Source
